Home › Guides › HRT and mood

HRT and mood — the neurological case for hormones

Anxiety arriving from nowhere. Rage faster than anything before. Depression that appears without history. The emotional changes of perimenopause are real, specific, and neurological — not psychological weakness. And for many women, HRT is the most direct treatment available.

Rose

"The anxiety arrived before anything else for me. Overnight, without obvious cause. I was told it was stress. It was perimenopause — specifically, falling progesterone removing the GABA support my brain had relied on for decades. Understanding that distinction — neurochemistry versus psychology — changed everything about how I approached it."

This is not depression. It is neurochemistry.

Perimenopausal mood disruption is a distinct clinical entity from major depressive disorder — it has a specific timing, specific triggers, and specific treatments. Many women are diagnosed with depression and prescribed antidepressants when the correct treatment is hormonal. Antidepressants are not ineffective — but they address the downstream symptoms rather than the upstream cause. For a woman in perimenopause, the correct first question is: is this hormonal?

Why hormones drive emotional change

🧠

Estrogen is a neuromodulator

Estrogen receptors are concentrated in the limbic system — the brain's emotional centre. Estrogen directly increases the synthesis and sensitivity of serotonin receptors, upregulates dopamine signalling in the prefrontal cortex, enhances GABA activity (the brain's calming neurotransmitter), and supports the production of noradrenaline. When estrogen falls in perimenopause, all four of these systems are disrupted simultaneously. The result is not a mood disorder — it is neurochemistry.

🌙

Progesterone: the anxiety buffer that drops first

Progesterone is metabolised to allopregnanolone — a potent positive allosteric modulator of GABA-A receptors. It is the brain's natural anxiolytic and the reason progesterone is sometimes described as the "calming hormone." In perimenopause, progesterone is the first hormone to decline — often years before estrogen falls significantly. Many women experience the anxiety, 3am waking, and emotional volatility of early perimenopause as progesterone withdrawal — even when estrogen is still fluctuating normally.

😴

Sleep deprivation compounds everything

A single night of poor sleep measurably impairs emotional regulation, increases amygdala reactivity (the threat-detection centre), and reduces prefrontal cortex activity (the rational override centre). Perimenopausal women living through months of night sweats and fragmented sleep are functioning with chronically impaired emotional regulation — independent of any direct hormonal effect on mood. Treating sleep is treating mood.

⚡

Cortisol and the threat-detection cascade

Falling estrogen impairs the HPA axis's ability to terminate the cortisol stress response. In perimenopausal women, cortisol elevation is both higher and more prolonged after stressors than in premenopausal women. This is experienced as disproportionate rage, anxiety that feels "stuck," and an inability to return to calm. This is not a character defect or poor coping — it is an impaired cortisol off-switch.

The specific emotional symptoms

🔥

Rage

Faster, more intense, and triggered by things that would not have previously caused it. This is the cortisol off-switch failing — the HPA axis no longer dampens the stress response efficiently.

😟

Anxiety

Often the first symptom — frequently appearing before hot flashes or period changes. Progesterone's decline removes the GABA support the brain has relied on. Can manifest as persistent low-level dread, panic attacks, or health anxiety.

😢

Low mood and depression

Distinct from lifelong depression — it has a hormonal trigger and typically responds to hormonal treatment. Often described as "not feeling like myself" rather than the classic anhedonia of major depression.

😤

Irritability

A lower threshold for frustration, a shorter fuse. Particularly pronounced in the week before a period — the cyclical progesterone drop is the most likely driver.

💭

Emotional volatility

Tears for no reason, laughter turning to tears, emotional responses that feel disproportionate. Limbic system dysregulation from estrogen and progesterone fluctuation.

😰

The 3am wake with dread

Waking at 3am with a sense of impending doom — often with heart racing. This is the nocturnal cortisol peak meeting low progesterone. Micronised progesterone at bedtime resolves this for most women.

What the evidence shows

SWAN study (17,000 women, longitudinal)

The Study of Women's Health Across the Nation found that perimenopause was an independent risk period for first onset of depression — even in women with no prior psychiatric history. The peri-to-postmenopausal transition was the highest-risk window.

E3N cohort and HRT mood effects

The E3N French cohort study found that women using HRT had significantly lower rates of depressive symptoms. Transdermal estradiol showed the strongest protective effect on mood — consistent with its direct neurological access versus oral forms.

KEEPS trial (cognitive and affective substudy)

The Kronos Early Estrogen Prevention Study found that women who received transdermal estradiol within the critical window reported significantly better mood scores and reduced depressive symptoms compared to placebo — and significantly better outcomes than women who received oral conjugated estrogen.

Progesterone and anxiety — the GABA connection

Multiple studies confirm that micronised progesterone (which crosses the blood-brain barrier and is metabolised to allopregnanolone) has measurable anxiolytic and sleep-promoting effects. Synthetic progestogens do not share this benefit — and some may worsen mood, which is one of the reasons micronised progesterone is now the preferred form in modern HRT protocols.

What actually helps

💊

Transdermal estradiol — the direct neurological intervention

Strong

Transdermal estradiol directly restores the four neurotransmitter systems disrupted by estrogen decline: serotonin, dopamine, GABA, and noradrenaline. Most women who start HRT report noticeable mood improvement within 3-6 weeks — often describing it as "feeling like themselves again." Transdermal is preferred over oral for mood because it provides stable, continuous estradiol levels without the peaks and troughs of oral dosing, and bypasses first-pass liver metabolism which converts estradiol to estrone. The KEEPS trial specifically found transdermal outperformed oral for mood outcomes.

Types of HRT — transdermal vs oral →The HRT story — what the evidence shows →

🌙

Micronised progesterone — the anxiety treatment hiding in plain sight

Strong

Micronised progesterone (Utrogestan, Prometrium) crosses the blood-brain barrier and is metabolised to allopregnanolone. At bedtime dosing, it acts as a natural anxiolytic and significantly improves sleep quality and architecture. Women who add micronised progesterone to their estradiol — especially at 200mg at bedtime — often report that the anxiety and 3am waking that characterised their perimenopause resolve within days. This is one of the most underutilised benefits of body-identical HRT.

Progesterone — the full guide →

😴

Sleep as primary treatment for mood

Strong

Emotional regulation is inseparable from sleep quality. Treating the sleep disruption of perimenopause — through vaginal estrogen for night sweats, micronised progesterone for its GABA effect, and sleep hygiene — directly improves mood. Cognitive Behavioural Therapy for Insomnia (CBT-I) has strong evidence and improves slow-wave sleep beyond just duration.

Sleep and menopause — the complete guide →

🏋️

Resistance training — BDNF and the antidepressant effect

Strong

Resistance training produces BDNF (brain-derived neurotrophic factor), which has direct antidepressant and anxiolytic effects through neuroplasticity promotion. Multiple RCTs show resistance training outperforms aerobic exercise specifically for mood improvement in menopausal women. The effect is dose-dependent and appears within 8-12 weeks of consistent training.

Exercise at menopause — the evidence-based guide →

🌿

Targeted supplements

Moderate

Magnesium glycinate supports GABA function and directly reduces anxiety — evidence strongest for glycinate form over oxide. Ashwagandha (KSM-66 standardised extract) reduces cortisol and has multiple RCTs for anxiety reduction. Saffron (Crocus sativus, 30mg standardised) has several meta-analyses supporting antidepressant effects comparable to low-dose SSRIs in mild-moderate depression. Omega-3 (particularly EPA >1g/day) has consistent meta-analytic support for depression reduction.

Supplement library — evidence grades →

🧘

Mind-body interventions

Moderate

Mindfulness-Based Cognitive Therapy (MBCT) has strong evidence for depression relapse prevention. CBT specifically adapted for menopause (menopause-CBT) has good evidence for hot flashes and mood. Yoga has moderate evidence for anxiety and mood in menopausal women. These are most effective as complements to HRT, not substitutes — combining hormonal and psychological approaches consistently outperforms either alone.

Mental health and menopause — the full guide →

HRT versus antidepressants — the conversation to have

When antidepressants are offered instead of HRT

Many women in perimenopause are prescribed SSRIs or SNRIs for mood symptoms without a discussion of hormonal causes or HRT. Antidepressants are not wrong — for some women they provide meaningful relief and are the right choice. But they are treating downstream symptoms rather than upstream cause when the mood disruption is hormonal.

The questions to ask: "Have we discussed whether my mood symptoms might be related to perimenopause? Have we considered HRT as a first-line option before antidepressants? What is the reason you are recommending an antidepressant rather than addressing the hormonal cause?"

If you are already on an antidepressant and believe the cause was hormonal: it is worth discussing HRT alongside, or instead of, the antidepressant with a menopause-literate doctor. The combination of HRT and an antidepressant is sometimes appropriate; replacing one with the other is sometimes more appropriate. Only a doctor who understands both can make that assessment.

What to say to your doctor

• "I am experiencing significant mood symptoms — anxiety, rage, and low mood — that arrived in my mid-40s without prior psychiatric history. I believe these may be perimenopause-related. I would like to discuss whether HRT, and specifically transdermal estradiol and micronised progesterone, would be appropriate before considering antidepressants."

• "I am waking at 3am with anxiety and dread. I understand this is associated with falling progesterone in perimenopause. Can we discuss micronised progesterone at bedtime as a first-line option?"

• "I have been prescribed antidepressants for mood symptoms. Before I start them, can we discuss whether my symptoms are hormonal in origin, and whether HRT would be a more targeted treatment?"

• "My mood symptoms are significantly worse in the week before my period — which suggests a cyclical hormonal component. Can we discuss whether this pattern indicates early perimenopause?"

Rose on this

"The rage, the 3am dread, the anxiety that arrived overnight — these were the hardest symptoms for me, because they felt like who I was becoming. They were not. They were four neurotransmitter systems disrupted by one hormonal transition. Understanding that distinction — neurochemistry, not character — was the turning point. And for most women, treating the hormones treats the mood. That is not a small thing to know."